AIRLINK 60.84 Increased By ▲ 1.14 (1.91%)
BOP 6.32 Increased By ▲ 0.06 (0.96%)
CNERGY 4.32 Increased By ▲ 0.05 (1.17%)
DFML 15.91 Increased By ▲ 0.21 (1.34%)
DGKC 69.12 Decreased By ▼ -0.08 (-0.12%)
FCCL 18.11 Decreased By ▼ -0.24 (-1.31%)
FFBL 26.37 Decreased By ▼ -0.38 (-1.42%)
FFL 9.18 Decreased By ▼ -0.10 (-1.08%)
GGL 10.21 Decreased By ▼ -0.09 (-0.87%)
HBL 117.06 Increased By ▲ 1.16 (1%)
HUBC 114.31 Decreased By ▼ -0.09 (-0.08%)
HUMNL 6.87 Increased By ▲ 0.07 (1.03%)
KEL 4.87 Decreased By ▼ -0.02 (-0.41%)
KOSM 5.36 Increased By ▲ 0.71 (15.27%)
MLCF 38.50 Increased By ▲ 0.11 (0.29%)
OGDC 123.33 Decreased By ▼ -1.97 (-1.57%)
PAEL 21.78 Increased By ▲ 0.22 (1.02%)
PIAA 11.80 Increased By ▲ 0.93 (8.56%)
PIBTL 6.08 Increased By ▲ 0.06 (1%)
PPL 113.07 Decreased By ▼ -1.03 (-0.9%)
PRL 28.22 Increased By ▲ 0.32 (1.15%)
PTC 11.39 Increased By ▲ 0.49 (4.5%)
SEARL 51.91 Increased By ▲ 0.21 (0.41%)
SNGP 67.35 Decreased By ▼ -0.91 (-1.33%)
SSGC 11.29 Decreased By ▼ -0.13 (-1.14%)
TELE 7.78 Decreased By ▼ -0.02 (-0.26%)
TPLP 11.54 Decreased By ▼ -0.06 (-0.52%)
TRG 71.72 Decreased By ▼ -1.15 (-1.58%)
UNITY 23.04 Decreased By ▼ -0.51 (-2.17%)
WTL 1.29 Decreased By ▼ -0.01 (-0.77%)
BR100 6,717 Increased By 68.3 (1.03%)
BR30 22,517 Decreased By -52.7 (-0.23%)
KSE100 65,326 Increased By 747.2 (1.16%)
KSE30 22,146 Increased By 256.6 (1.17%)
Pakistan

Interior Minister Ijaz Shah gets first dose of COVID-19 trial vaccine

  • UHS Vice-Chancellor Prof Javed Akram says the minister’s staff members were also administered the trial vaccine
  • China had supplied the medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement
Published December 7, 2020

(Karachi) Federal Interior Minister Ijaz Shah has been administered trial vaccine of COVID-19 from China at the University of Health Sciences (UHS) Lahore, local media reported on Monday.

“Interior Minister Ijaz Shah was administered the vaccine, which has been in phase three of clinical trials,” UHS Vice-Chancellor Prof Dr Javed Akram said.

“The minister’s staff members were also administered the trial vaccine,” Prof Akram added.

Earlier, Pakistan began final-phase testing of a Chinese-made vaccine against novel coronavirus, the first ever clinical trial of its kind in the South Asian nation.

China had supplied the COVID-19 medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement.

So far, the trial vaccine has seen a positive public response, raising the hope that the effort would meet its target. The specific vaccine has already established its safety and efficacy in the previous trials held in China with no serious adverse effects.

It’s now being tested on a wider population in Russia, Mexico, Chile, Argentina, Saudi Arabia and Pakistan; the country has been allocated 8,000 recruits out of a total of 40,000 and is currently conducting the trial at five centres in Islamabad, Lahore and Karachi.

Comments

Comments are closed.